Thursday, 1 September 2016

Novo Nordisk CEO Lars Rebien Sorensen to step down by end 2016

COPENHAGEN (Reuters) - Danish insulin maker Novo Nordisk's Chief Executive Lars Rebien Sorensen will step down by the end of 2016 after 16 years in the position, it said on Thursday.


No comments:

Post a Comment